Next Article in Journal
Cytoskeletal Regulation of Inflammation and Its Impact on Skin Blistering Disease Epidermolysis Bullosa Acquisita
Next Article in Special Issue
MicroRNA-155 Mediates Augmented CD40 Expression in Bone Marrow Derived Plasmacytoid Dendritic Cells in Symptomatic Lupus-Prone NZB/W F1 Mice
Previous Article in Journal
Human Aquaporin-4 and Molecular Modeling: Historical Perspective and View to the Future
Previous Article in Special Issue
miR-494-3p Induces Cellular Senescence and Enhances Radiosensitivity in Human Oral Squamous Carcinoma Cells
Article Menu
Issue 7 (July) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2016, 17(7), 1120;

MicroRNAs in Valvular Heart Diseases: Potential Role as Markers and Actors of Valvular and Cardiac Remodeling

GIGA-Cardiovascular Sciences, Interdisciplinary Cluster for Applied Genoproteomics (GIGA), University of Liège, 4000 Liège, Belgium
Department of Cardiology, University of Liège Hospital, 4000 Liège, Belgium
Experimental and Molecular Pathology Laboratory, Insitute of Pathology Ludwig Maximilians, University Munich, 80331 Munich, Germany
Gruppo Villa Maria Care and Research, Anthea Hospital, 70124 Bari, Italy
Author to whom correspondence should be addressed.
Academic Editor: Y-h. Taguchi
Received: 21 April 2016 / Revised: 4 July 2016 / Accepted: 8 July 2016 / Published: 13 July 2016
(This article belongs to the Special Issue MicroRNA Regulation)
Full-Text   |   PDF [1273 KB, uploaded 13 July 2016]   |  


miRNAs are a class of over 5000 noncoding RNAs that regulate more than half of the protein-encoding genes by provoking their degradation or preventing their translation. miRNAs are key regulators of complex biological processes underlying several cardiovascular disorders, including left ventricular hypertrophy, ischemic heart disease, heart failure, hypertension and arrhythmias. Moreover, circulating miRNAs herald promise as biomarkers in acute myocardial infarction and heart failure. In this context, this review gives an overview of studies that suggest that miRNAs could also play a role in valvular heart diseases. This area of research is still at its infancy, and further investigations in large patient cohorts and cellular or animal models are needed to provide strong data. Most studies focused on aortic stenosis, one of the most common valvular diseases in developed countries. Profiling and functional analyses indicate that miRNAs could contribute to activation of aortic valve interstitial cells to a myofibroblast phenotype, leading to valvular fibrosis and calcification, and to pressure overload-induced myocardial remodeling and hypertrophy. Data also indicate that specific miRNA signatures, in combination with clinical and functional imaging parameters, could represent useful biomarkers of disease progression or recovery after aortic valve replacement. View Full-Text
Keywords: microRNAs; valvular heart diseases; biomarkers; cellular and animal models microRNAs; valvular heart diseases; biomarkers; cellular and animal models

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Oury, C.; Servais, L.; Bouznad, N.; Hego, A.; Nchimi, A.; Lancellotti, P. MicroRNAs in Valvular Heart Diseases: Potential Role as Markers and Actors of Valvular and Cardiac Remodeling. Int. J. Mol. Sci. 2016, 17, 1120.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top